Related Experiment Video
Updated: Jan 19, 2026

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma
Yuhang Chai1, Qihang Li1, Hongying Zhao2
1Department of Pathology and Key Laboratory of Xinjiang Endemic and Ethnic Diseases/the First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, China.
Abstract:
Whether SOX2 and ACTL6A/TP63 interact with the Hippo-YAP1 pathway in esophageal squamous cell carcinoma (ESCC) remains unclear. Here, we reveal that SOX2, ACTL6A, and TP63 are co-amplified and upregulated in ESCC samples. Multiple SOX2 binding peaks in the locus of WWC1, a Hippo-YAP1 regulator, and an inverse correlation between the expression of SOX2 and WWC1 are identified, suggesting direct repression of WWC1 by SOX2. Expression scores of SOX2 are higher in tumors than normal tissues and positively correlated with nuclear YAP1 staining in primary ESCC. Moreover, SOX2 gain-of-function significantly promotes nuclear YAP1 expression in ESCC cells while silencing of SOX2 expression inhibits YAP1 activation. SOX2 overexpression leads to a significant enhancement of cell migration and invasion as well as chemoresistance to cisplatin, whereas knockdown of SOX2 or ectopic expression of WWC1 suppresses the SOX2-induced migration ability and invasive potential. Disruption of this SOX2-WWC1-YAP1 axis could be a therapeutic strategy for SOX2-dependent tumors.
Insights
SOX2, ACTL6A, and TP63 are amplified in esophageal squamous cell carcinoma (ESCC). These factors repress WWC1, activating the Hippo-YAP1 pathway, driving tumor progression and chemoresistance.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The role of SOX2, ACTL6A, and TP63 in the Hippo-YAP1 pathway in esophageal squamous cell carcinoma (ESCC) is not well understood.
- Investigating these interactions is crucial for understanding ESCC pathogenesis.
Purpose of the Study:
- To elucidate the interaction between SOX2, ACTL6A, TP63, and the Hippo-YAP1 pathway in ESCC.
- To determine the functional consequences of this interaction on tumor progression and chemoresistance.
Main Methods:
- Analysis of gene amplification and expression in ESCC samples.
- Chromatin immunoprecipitation sequencing to identify SOX2 binding sites.
- Correlation analysis between gene expression and YAP1 localization.
- Gain-of-function and knockdown experiments in ESCC cell lines.
Main Results:
- SOX2, ACTL6A, and TP63 are co-amplified and upregulated in ESCC.
- SOX2 directly represses WWC1, a Hippo-YAP1 pathway regulator.
- SOX2 promotes nuclear YAP1 expression, enhancing cell migration, invasion, and cisplatin chemoresistance.
- WWC1 ectopic expression or SOX2 knockdown suppresses SOX2-induced phenotypes.
Conclusions:
- A novel SOX2-WWC1-YAP1 axis is identified in ESCC.
- This axis drives tumor progression and chemoresistance.
- Targeting this axis presents a potential therapeutic strategy for SOX2-dependent ESCC.
Related Concept Videos
Pleiotropy
Induced Pluripotent Stem Cells
Somatic...
Canonical Wnt Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Inheritance of Chromatin Structures

